Thrombosis Concept

subject area of

• 2 Mechanisms of action of low molecular weight heparins and heparinoids  Academic Article
• 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis  Academic Article
• 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19  Academic Article
• A 14-year study of heparin-induced thrombocytopenia  Academic Article
• A Canadian multicenter experience describing outcomes after endovascular abdominal aortic aneurysm repair stent graft explantation  Academic Article
• A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis  Academic Article
• A Hungry Thrombus  Academic Article
• A National Survey of Canadian Practice Patterns of Warfarin After Anterior Wall Myocardial Infarction in the Current Era of Dual Antiplatelet Therapy  Academic Article
• A New Short Infusion Dosage Regimen of Recombinant Tissue Plasminogen Activator in Patients with Venous Thromboembolic Disease  Academic Article
• A Patient with Hemodialysis Access Problems  Academic Article
• A Replacement for Warfarin  Academic Article
• A Spontaneous Prothrombotic Disorder Resembling Heparin-induced Thrombocytopenia  Academic Article
• A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin–antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen  Academic Article
• A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparation  Academic Article
• A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID‐19  Academic Article
• A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss  Academic Article
• A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders  Academic Article
• A novel mechanism of erythrocyte capture from circulation in humans  Academic Article
• A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation  Academic Article
• A plasmin-activatable thrombin inhibitor reduces experimental thrombosis and assists experimental thrombolysis in murine models  Academic Article
• A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery  Academic Article
• A randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643]  Academic Article
• A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations  Academic Article
• A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies  Academic Article
• ABC of antithrombotic therapy: Valvar heart disease and prosthetic heart valves  Academic Article
• AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation  Academic Article
• ARTERIAL THROMBOSIS IN A PATIENT WITH CHRONIC THROMBOCYTOPENIA SUCCESSFUL TREATMENT WITH INTRAARTERIAL INFUSION OF STREPTOKINASE  Academic Article
• ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease  Academic Article
• ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease  Academic Article
• ASSOCIATION BETWEEN BREUS' MOLE AND PARTIAL HYDATIDIFORM MOLE: CHANCE OR CAN HYDROPIC VILLI PRECIPITATE PLACENTAL MASSIVE SUBCHORIONIC THROMBOSIS?  Academic Article
• Abnormal hemostasis in a knock‐in mouse carrying a variant of factor IX with impaired binding to collagen type IV  Academic Article
• Accelerated Infusion of Streptokinase for the Treatment of Left-Sided Prosthetic Valve Thrombosis  Academic Article
• Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin  Academic Article
• Accuracy of Doppler echocardiography for the diagnosis of thrombosis associated with umbilical venous catheters  Academic Article
• Accuracy of clinical assessment of deep-vein thrombosis  Academic Article
• Accuracy of efficient data methods to determine the incidence of hospital-acquired thrombosis and major bleeding in medical and surgical inpatients: a multicentre observational cohort study in four UK hospitals  Academic Article
• Action of Gold Sodium Thiomalate on Experimental Thrombosis In Vivo  Academic Article
• Activated Clotting Time and Outcomes During Percutaneous Coronary Intervention for Non–ST-Segment–Elevation Myocardial Infarction  Academic Article
• Activation of factor X and prothrombin in antithrombin-III depleted plasma: The effects of heparin  Academic Article
• Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process  Academic Article
• Addressing the burden of hospital‐related venous thromboembolism: the role of extended anticoagulant prophylaxis  Academic Article
• Adhesion of platelets to artificial surfaces: Effect of red cells  Academic Article
• Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia  Academic Article
• Adjunctive Use of Direct Thrombin Inhibitors in Patients Receiving Fibrinolytic Therapy for Acute Myocardial Infarction  Academic Article
• Advances in Antithrombotic Therapy  Academic Article
• Advances in Thrombosis and Hemostasis  Academic Article
• Alpha-1 proteinase inhibitor M358R reduces thrombin generation when displayed on the surface of cells expressing tissue factor  Academic Article
• Altered levels of antithrombin III and fibrinogen in the aortic wall of the alloxan-induced diabetic rabbit: evidence of a prothrombotic state.  Academic Article
• American College of Chest Physicians Guidelines for Heparin-Induced Thrombocytopenia: Response  Academic Article
• An Acute Febrile Pleiochromic Anemia with Hyaline Thrombosis of the Terminal Arterioles and Capillaries (Moschcowitz 1925)  Academic Article
• An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic Patients  Academic Article
• An Overview of the Heparin-Induced Thrombocytopenia Syndrome  Academic Article
• An overview of the mechanism of action of antithrombin and its inherited deficiency states  Academic Article
• Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors  Academic Article
• Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban  Academic Article
• Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis  Academic Article
• Animal Models of Thrombosis From Zebrafish to Nonhuman Primates  Academic Article
• Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial  Academic Article
• Anti-prothrombin antibodies and other acquired antibodies associated with thrombosis in children  Academic Article
• Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?  Academic Article
• Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia  Academic Article
• Anticardiolipin Antibody and Anti-beta 2 Glycoprotein I Antibody Assays  Academic Article
• Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls  Academic Article
• Anticoagulant therapy after acute myocardial infarction  Academic Article
• Anticoagulant therapy following acute myocardial infarction. Part I. Incidence of and factors predisposing to thromboembolism associated with acute myocardial infarction.  Academic Article
• Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?  Academic Article
• Anticoagulation for perioperative thromboprophylaxis in people with cancer  Academic Article
• Anticoagulation therapy in patients with prosthetic heart valves.  Academic Article
• Anticoagulation therapy in the antiphospholipid syndrome: recent advances  Academic Article
• Antiphospholipid Syndrome and the Aorta: A Rare Presentation  Academic Article
• Antiphospholipid antibodies in critical illness  Academic Article
• Antiphospholipid antibody syndrome: diffuse alveolar hemorrhage and Libman-Sacks endocarditis in the absence of prior thrombotic events.  Conference Paper
• Antiphospholipid antibody syndrome: further evidence to guide clinical practice?  Academic Article
• Antiphospholipid antibody syndrome: recent findings on managing this challenging condition.  Academic Article
• Antiphospholipid syndrome  Academic Article
• Antiphospholipid syndrome  Academic Article
• Antiplatelet Agents: Rationale and Results  Academic Article
• Antiplatelet Drugs  Academic Article
• Antiplatelet Therapy  Academic Article
• Antiplatelet Therapy and Vascular-Access Patency  Academic Article
• Antiplatelet drugs  Academic Article
• Antiplatelet therapy in the management of atherothrombosis: recent clinical advances  Academic Article
• Antithrombin-Heparin Covalent Complex  Academic Article
• Antithrombins: Their Potential as Antithrombotic Agents  Academic Article
• Antithrombotic Activity of the Novel Oral Anticoagulant, Tecarfarin [Sodium 3-[4-((1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yloxy) carbonyl) benzyl]-2-oxo-2H-chromen-4-olate] in Animal Models  Academic Article
• Antithrombotic Agents  Academic Article
• Antithrombotic Drugs  Academic Article
• Antithrombotic Management After Transcatheter Aortic Valve Replacement: A Survey of Canadian Physicians  Academic Article
• Antithrombotic Properties of Heparin in a Neonatal Piglet Model of Thrombin-Induced Thrombosis  Academic Article
• Antithrombotic Therapy in Neonates and Children  Academic Article
• Antithrombotic and bleeding effects of glycosaminoglycans with different degrees of sulphation  Academic Article
• Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.  Academic Article
• Antithrombotic therapy in aortic diseases: A narrative review  Academic Article
• Antithrombotic therapy in children with venous thromboembolism  Academic Article
• Antithrombotic therapy. Introduction.  Academic Article
• Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis  Academic Article
• Anti‐PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non‐drug risk factors and evidence for a stoichiometry‐based model of immunization  Academic Article
• Any review must carefully weigh the available evidence  Academic Article
• Application of Combinatorial Libraries and Protein Engineering to the Discovery of Novel Anti-Thrombotic Drugs  Conference Paper
• Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen  Academic Article
• Applying new strategies for the national adaptation, updating, and dissemination of trustworthy guidelines: results from the Norwegian adaptation of the antithrombotic therapy and the prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Academic Article
• Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Academic Article
• Are risk factors for atherothrombotic disease associated with back pain sickness absence? The Whitehall II Study  Academic Article
• Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein  Academic Article
• Arteriovenous-Shunt Thrombosis  Academic Article
• Article Commentary: Heparin and the Peritoneal Membrane  Academic Article
• Aspirin  Academic Article
• Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects.  Academic Article
• Aspirin in the treatment of cardiovascular disease: A review  Academic Article
• Aspirin resistance: does it exist and is it an important clinical problem?  Academic Article
• Aspirin resistance: position paper of the Working Group on Aspirin Resistance  Academic Article
• Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding  Academic Article
• Association between inflammation biomarkers, anatomic extent of deep venous thrombosis, and venous symptoms after deep venous thrombosis  Academic Article
• Association between perioperative low-molecular-weight heparin vs unfractionated heparin and clinical outcomes in patients with cancer undergoing surgery  Academic Article
• Association of Factor V Leiden With Subsequent Atherothrombotic Events  Academic Article
• Association of Stent-Retriever Characteristics in Establishing Successful Reperfusion During Mechanical Thrombectomy  Academic Article
• Atherogenesis and Its Relation to Stroke  Academic Article
• Atherosclerosis. Current Concept  Article
• Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis  Academic Article
• Atrial mass in a pregnant patient with antiphospholipid antibody syndrome  Academic Article
• BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 receptor and phosphodiesterase  Academic Article
• Bare metal versus drug eluting stents for ST-segment elevation myocardial infarction in the TOTAL trial  Academic Article
• Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey  Academic Article
• Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia  Academic Article
• Berzelius Symposium 93: International Conference on Thrombosis and Embolism  Academic Article
• Beyond Unfractionated Heparin and Warfarin  Academic Article
• Bioregulatory roles for fibrin(ogen) on blood coagulation  Academic Article
• Bivalirudin  Academic Article
• Bivalirudin, thrombin and platelets: clinical implications and future directions.  Academic Article
• Bleeding and thrombotic problems in a patient with alpha2 plasmin inhibitor deficiency  Academic Article
• Bleeding associated with antithrombotic therapy.  Academic Article
• Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology  Academic Article
• Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis  Academic Article
• Blood tests for the diagnosis of venous and arterial thrombosis  Academic Article
• Breast cancer chemotherapy induces the release of cell‐free DNA, a novel procoagulant stimulus  Academic Article
• CHANGES IN PLATELET BEHAVIOUR DURING ARVIN THERAPY  Academic Article
• COVID-19 coagulopathy, thrombosis, and bleeding  Academic Article
• COVID-19 in thrombosis research: An editorial perspective  Academic Article
• COVID-19 versus HIT hypercoagulability  Academic Article
• Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib  Academic Article
• Carotid artery dissections: Thrombosis of the false lumen  Academic Article
• Case Report: Two Cases of Strongyloidiasis Presenting with Thrombotic Events  Academic Article
• Catheter-Related Right Atrial Thrombus and Pulmonary Embolism: A Case Report and Systematic Review of the Literature  Academic Article
• Central venous catheters are an important factor in paediatric thrombosis  Academic Article
• Challenges and Priorities for Research  Academic Article
• Changing profile of Budd Chiari syndrome in India.  Academic Article
• Characterization of a Mouse Model for Thrombomodulin Deficiency  Academic Article
• Characterization of mice harboring a variant of EPCR with impaired ability to bind protein C: novel role of EPCR in hematopoiesis  Academic Article
• Chemotherapy enhances endothelial cell reactivity to platelets  Academic Article
• Chronic venous abnormalities in symptomatic and asymptomatic protein C deficiency  Academic Article
• Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis  Academic Article
• Clinical presentation of heparin-induced thrombocytopenia.  Academic Article
• Clinical trial opportunities in hemostasis and thrombosis: NHBLI State-of-the-science symposium  Academic Article
• Clinical trials of new anticoagulants.  Academic Article
• Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events  Academic Article
• Coagulation: Consultative Hemostasis  Academic Article
• Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial  Academic Article
• Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease  Academic Article
• Combined Antiplatelet Therapy in Atrial Fibrillation:  Academic Article
• Combined administration of barbourin–albumin and hirudin–albumin fusion proteins limits fibrin(ogen) deposition on the rabbit balloon-injured aorta  Academic Article
• Comments on the Important Drug Interaction of Warfarin and Sulfamethoxazole  Academic Article
• Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis: A Survey on Anticoagulation for Mechanical Heart Valves in Pregnancy  Academic Article
• Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance.  Academic Article
• Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin  Academic Article
• Comparison of recombinant and plasma-derived antithrombin biodistribution in a rabbit model  Academic Article
• Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism  Academic Article
• Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-iii affinity heparin fraction  Academic Article
• Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II  Academic Article
• Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS  Academic Article
• Complement and the antiphospholipid syndrome  Academic Article
• Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study  Academic Article
• Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting  Academic Article
• Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: a descriptive study  Academic Article
• Contrast-enhancing left ventricular apical thrombus  Academic Article
• Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms  Academic Article
• Corn trypsin inhibitor coating attenuates the prothrombotic properties of catheters in vitro and in vivo  Academic Article
• Coronary artery stenting in patients treated by clopidogrel without aspirin  Academic Article
• Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist  Academic Article
• Critical evaluation of platelet-inhibiting drugs in thrombotic disease.  Academic Article
• Current anticoagulant therapy—unmet clinical needs  Conference Paper
• Current use of biologicals in thrombosis and haemostasis  Academic Article
• Cutaneous collagenous vasculopathy associated with intravascular occlusive fibrin thrombi  Academic Article
• Cyclooxygenase-2 Inhibitors  Academic Article
• D-Dimer Assays in Diagnosis and Management of Thrombotic and Bleeding Disorders  Academic Article
• DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE  Academic Article
• Dabigatran for patients with a mechanical valve  Academic Article
• Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial  Academic Article
• Deep Vein Thrombosis: Recovery or Recurrence?  Academic Article
• Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access  Academic Article
• Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis  Academic Article
• Delivery of passivating proteins to sutures during passage through the vessel wall reduces subsequent platelet deposition by blocking fibrinogen adsorption.  Academic Article
• Dermatomyositis associated with platelet thrombi formation and responsive to antiplatelet therapy.  Academic Article
• Diagnosis of DVT  Academic Article
• Diagnostic Problems with Venous Thromboembolic Disease in Pregnancy  Academic Article
• Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet‐mediated events during thrombus formation  Academic Article
• Dietary Supplementation With Methionine and Homocysteine Promotes Early Atherosclerosis but Not Plaque Rupture in ApoE-Deficient Mice  Academic Article
• Direct Portal Vein Thrombosis Visualization with T2*-Weighted Magnetic Resonance Imaging  Academic Article
• Direct Thrombin Inhibitors in Acute Coronary Syndromes  Academic Article
• Direct thrombin inhibitors  Academic Article
• Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fraction  Academic Article
• Dosage Regimens for Streptokinase Treatment: Evaluation of a Standard Dosage Schedule  Academic Article
• Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial  Academic Article
• Drug-Induced Immune-Mediated Thrombocytopenia — From Purpura to Thrombosis  Academic Article
• Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events  Academic Article
• Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances.  Academic Article
• Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease  Academic Article
• Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia  Academic Article
• EXPERIMENTAL PRODUCTION OF MICROANGIOPATHIC HÆMOLYTIC ANÆMIA IN VIVO  Academic Article
• Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation  Academic Article
• Effect of Atrial Fibrillation on Atrial Thrombogenesis in Humans: Impact of Rate and Rhythm  Academic Article
• Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model  Academic Article
• Effect of Drugs on Platelets and Complications of Vascular Disease  Article
• Effect of Fish Oil Supplementation on Graft Patency and Cardiovascular Events Among Patients With New Synthetic Arteriovenous Hemodialysis Grafts  Academic Article
• Effect of Reversal of Neuromuscular Blockade with Sugammadex versus Usual Care on Bleeding Risk in a Randomized Study of Surgical Patients  Academic Article
• Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits.  Academic Article
• Effect of anti‐platelet factor‐4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery  Academic Article
• Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits.  Academic Article
• Effect of covalent antithrombin-heparin complex on developmental mechanisms in the lung  Academic Article
• Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA.  Academic Article
• Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers  Academic Article
• Effect of streptokinase therapy on experimental fibrin-rich arterial thrombi.  Academic Article
• Effect of ticlopidine on platelet aggregation, adherence to damaged vessels, thrombus formation and platelet survival  Academic Article
• Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial  Academic Article
• Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty  Academic Article
• Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials  Academic Article
• Emerging anticoagulant strategies  Academic Article
• Emicizumab and thrombosis: The story so far  Academic Article
• Enoxaparin Use in the Neonatal Intensive Care Unit: Experience Over 8 Years  Academic Article
• Enoxaparin for neonatal thrombosis: A call for a higher dose for neonates  Academic Article
• Envelope glycoprotein of avian hemangioma retrovirus induces a thrombogenic surface on human and bovine endothelial cells  Academic Article
• Epidemiology of Thrombosis in Cancer  Academic Article
• Epidemiology of VITT.  Academic Article
• Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study  Academic Article
• EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis  Academic Article
• Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol  Academic Article
• Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study  Academic Article
• Evaluation of DNA aptamers directed to thrombin as potential thrombus imaging agents  Academic Article
• Evaluation of a Thromboprophylaxis Quality Improvement Project in a Palliative Care Unit  Academic Article
• Evaluation of direct oral anticoagulants in superficial-vein thrombosis – Authors' reply  Academic Article
• Evaluation of the Coagulation Profile Among Oral and Vaginal Combined Hormonal Contraceptive Users Using Sonoclot Coagulation Analyzer  Academic Article
• Evaluation of the Use of Low-Molecular-Weight Heparin in Neonates  Academic Article
• Evidence based treatment of the antiphospholipid syndromeII. Optimal anticoagulant therapy for thrombosis  Academic Article
• Evidence for the Needs of Out-of-Hospital Thrombosis Prophylaxis  Academic Article
• Evidence-Based Management of Anticoagulant Therapy  Academic Article
• Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor–associated major bleeding  Academic Article
• Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies  Academic Article
• Evolution of Thrombosis  Academic Article
• Executive summary: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Academic Article
• Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS)  Academic Article
• Experiences with a novel policy for managing conflicts of interest of guideline developers: a descriptive qualitative study  Academic Article
• Expert Approaches to Common Bleeding and Thrombotic Problems, Part II  Academic Article
• Expert Approaches to Common Bleeding and Thrombotic Problems—Part I  Academic Article
• Exploiting the current paradigm of blood–material interactions for the rational design of blood-compatible materials  Academic Article
• Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease  Academic Article
• External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry  Academic Article
• Extracellular DNA and histones: double‐edged swords in immunothrombosis  Academic Article
• Factor V Leiden and Thrombotic Complications in Heparin-induced Thrombocytopenia  Academic Article
• Factor XI Inhibition to Uncouple Thrombosis From Hemostasis  Academic Article
• Factor XI and factor XII as targets for new anticoagulants  Academic Article
• Factor XI as a Target for New Anticoagulants  Academic Article
• Factor XI inhibitors: cardiovascular perspectives  Academic Article
• Factor XI inhibitors: what should clinicians know  Academic Article
• Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial  Academic Article
• Factors That Predict Risk of Thrombosis in Relatives of Patients With Unprovoked Venous Thromboembolism  Academic Article
• Familial thrombophilia and the prothrombin 20210A mutation  Academic Article
• Feasibility and safety of enoxaparin whole milligram dosing in premature and term neonates  Academic Article
• Fibrin Clot Lysis by Thrombolytic Agents Is Impaired in Newborns due to a Low Plasminogen Concentration  Academic Article
• Fibrinolytic properties of lysine-derivatized polyethylene in contact with flowing whole blood (Chandler loop model)  Academic Article
• First-Line Therapy for Immune Thrombocytopenia  Academic Article
• Fluorinated surface-modifying macromolecules: Modulating adhesive protein and platelet interactions on a polyether-urethane  Academic Article
• Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy  Academic Article
• Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study  Academic Article
• Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke  Academic Article
• From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer  Academic Article
• Fusion to Human Serum Albumin Extends the Circulatory Half-Life and Duration of Antithrombotic Action of the Kunitz Protease Inhibitor Domain of Protease Nexin 2  Academic Article
• Genetics of Coagulation: What the Cardiologist Needs to Know  Academic Article
• Getting a GRP on Tissue Factor Activation  Academic Article
• Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH  Academic Article
• Grades of Recommendation for Antithrombotic Agents  Academic Article
• Guide to Anticoagulant Therapy: Heparin  Academic Article
• Guide to Anticoagulant Therapy: Heparin  Academic Article
• Guided Antithrombotic Therapy: Current Status and Future Research Direction  Academic Article
• Guidelines for Management of Left-Sided Prosthetic Valve Thrombosis: A Role for Thrombolytic Therapy 11These guidelines are the results of a Consensus Conference held during the Symposium on Prosthetic Valve Thrombosis on September 16, 1994, in Budapest, Hungary.  Academic Article
• HIT: still stringing us along  Academic Article
• Hazards of percutaneous PFO closure  Academic Article
• Hemostasis and atherosclerosis.  Academic Article
• Heparin and Platelets  Academic Article
• Heparin compromises streptokinase-induced arterial patency in rabbits  Academic Article
• Heparin for Mural Thrombosis in Anterior Myocardial Infarction  Academic Article
• Heparin for prolonging peripheral intravenous catheter use in neonates  Academic Article
• Heparin sensitivity and resistance in the neonate: An explanation  Academic Article
• Heparin-Associated Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia  Academic Article
• Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: Fraternal—Not Identical—Twins  Academic Article
• Heparin-Induced Thrombocytopenia in Patients with Ventricular Assist Devices: Are New Prevention Strategies Required?  Academic Article
• Heparin-Induced Thrombocytopenia: A Clinicopathologic Syndrome  Academic Article
• Heparin-Induced Thrombocytopenia: Real-World Issues  Academic Article
• Heparin-Induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-Induced thrombocytopenia  Academic Article
• Heparin-induced Thrombocytopenia  Academic Article
• Heparin-induced Thrombocytopenia: Towards Consensus  Academic Article
• Heparin-induced Thrombocytopenia: Yet Another Treatment Paradox?  Academic Article
• Heparin-induced thrombocytopenia  Academic Article
• Heparin-induced thrombocytopenia and cardiac surgery  Academic Article
• Heparin-induced thrombocytopenia and cardiac surgery  Academic Article
• Heparin-induced thrombocytopenia and its treatment.  Conference Paper
• Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies  Academic Article
• Heparin-induced thrombocytopenia in intensive care patients  Academic Article
• Heparin-induced thrombocytopenia in the critically ill: Interpreting the 4Ts test in a randomized trial  Academic Article
• Heparin-induced thrombocytopenia.  Academic Article
• Heparin-induced thrombocytopenia: an overview  Academic Article
• Heparin-induced thrombocytopenia: pathogenesis and management  Academic Article
• Heparin-induced thrombocytopenia: patient profiles and clinical manifestations.  Academic Article
• Heparin‐induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery ‘spontaneous’ HIT  Academic Article
• Heparin‐induced thrombocytopenia‐associated thrombosis: from arterial to venous to venous limb gangrene  Academic Article
• Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14–16, 2010, São Paulo, Brazil  Academic Article
• Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20–21, 2011, Salvador, Bahia, Brazil  Academic Article
• Highlights from the Tenth International Symposium of Thrombosis and Anticoagulation (ISTA X), September 22 and 23, 2017, Salvador, Bahia, Brazil  Academic Article
• High‐dose intravenous immunoglobulin to treat spontaneous heparin‐induced thrombocytopenia syndrome  Academic Article
• Hirudin and thrombosis prophylaxis  Academic Article
• Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation  Academic Article
• Histones link inflammation and thrombosis through the induction of Weibel–Palade body exocytosis  Academic Article
• Histoplasma Endocarditis Diagnosed by Thrombus Aspiration  Academic Article
• Homocysteine and vascular disease  Academic Article
• How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice  Academic Article
• How to use unfractionated heparin to treat neonatal thrombosis in clinical practice  Academic Article
• How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review  Academic Article
• Hypercoagulability and thrombosis in COVID-19: a modifiable cause for mortality?  Academic Article
• Hypercoagulability in Multiple Myeloma and Its Precursor State, Monoclonal Gammopathy of Undetermined Significance  Academic Article
• Hypercoagulability.  Academic Article
• Hypercoagulable States  Academic Article
• Hypothenar Hammer Syndrome From Ice Hockey Stick-Handling  Academic Article
• INTRAVASCULAR HÆMOLYSIS AND DISSEMINATED INTRAVASCULAR COAGULATION  Academic Article
• ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura  Academic Article
• Iatrogenic Disease in Late Life  Academic Article
• Idarucizumab for Dabigatran Reversal  Academic Article
• Idarucizumab for Dabigatran Reversal — Full Cohort Analysis  Academic Article
• Impact of Chemotherapy on Thrombin Generation and on the Protein C Pathway in Breast Cancer Patients  Academic Article
• Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients  Academic Article
• Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: A prospective evaluation  Academic Article
• Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial  Academic Article
• Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type1 diabetic patients  Academic Article
• In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets  Academic Article
• In Vivo Identification of Complicated Upper Thoracic Aorta and Arch Vessel Plaque by MR Direct Thrombus Imaging in Patients Investigated for Cerebrovascular Disease  Academic Article
• In Vivo Models of Platelet Function and Thrombosis: Study of Real-Time Thrombus Formation  Academic Article
• In vitro and ex vivo Activities of CY216: Comparison with Other Low Molecular Weight Heparins  Academic Article
• In vivo Effects of Low Molecular Weight Heparins on Experimental Thrombosis and Bleeding  Academic Article
• In vivo activity of a new heparinoid.  Academic Article
• In vivo rabbit acute model tests of polyurethane catheters coated with a novel antithrombin-heparin covalent complex  Academic Article
• In-vitro assessment of the effect of dabigatran on thrombosis of adult and neonatal plasma  Academic Article
• Incidence and Management of Thrombotic and Thromboembolic Complications Following the Norwood Procedure: A Systematic Review  Academic Article
• Incidence and Management of Thrombotic and Thromboembolic Complications Following the Superior Cavopulmonary Anastomosis Procedure: A Literature Review  Academic Article
• Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy  Academic Article
• Incidence of portal vein thrombosis after laparoscopic splenectomy.  Academic Article
• Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus  Academic Article
• Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With Cancer  Academic Article
• Increased heparin clearance in experimental pulmonary embolism.  Academic Article
• Increased platelet, but unaltered fibrinogen, accumulation in experimental thrombi in alloxan-induced diabetic rabbits  Academic Article
• Influence of blood clots in the cumulus complex on oocyte fertilization and cleavage  Academic Article
• Inhibition of Microsurgical Thrombosis by the Platelet Glycoprotein IIb/IIIa Antagonist SR121566A  Academic Article
• Inhibition of arterial thrombosis and platelet function by nafazatrom  Academic Article
• Initial Experience With Viabahn VBX as the Bridging Stent Graft for Branched and Fenestrated Endovascular Aneurysm Repair  Academic Article
• International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis  Academic Article
• International Society on Thrombosis and Haemostasis core curriculum project: core competencies in clinical thrombosis and hemostasis: comment  Academic Article
• International Society on Thrombosis and Haemostasis: Present and future  Academic Article
• International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis  Academic Article
• Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis  Academic Article
• Interruption of Warfarin Anticoagulation for Dental Surgery: Response  Academic Article
• Intimal hyperplasia and thrombosis of the visceral arteries in a young woman: possible relation with oral contraceptives and smoking.  Academic Article
• Intracardiac thrombus in adults with the Fontan circulation  Academic Article
• Intracellular lipid in clear cell renal cell carcinoma tumor thrombus and metastases detected by chemical shift (in and opposed phase) MRI: radiologic-pathologic correlation  Academic Article
• Intravascular Haemolysis with Experimentally Produced Vascular Thrombi  Academic Article
• Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia  Academic Article
• Introduction to the ninth edition: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Academic Article
• Is Heparin the Ideal Anticoagulant for Cardiopulmonary Bypass? Dermatan Sulphate May Be an Alternate Choice  Academic Article
• Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Still an open question  Academic Article
• Is low serum albumin level a significant predictor for the development of heparin-induced thrombocytopenia-thrombosis?  Academic Article
• Lack of consistency in the relationship between asymptomatic DVT detected by venography and symptomatic VTE in thromboprophylaxis trials  Academic Article
• Laparoscopic Management of Advanced Renal Cell Carcinoma With Renal Vein and Inferior Vena Cava Thrombus  Academic Article
• Lessons from vaccine-induced immune thrombotic thrombocytopenia  Academic Article
• Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysis  Academic Article
• Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development  Academic Article
• Life and limb protection with dual anti-thrombotic pathway inhibition: COMPASS ushers in a new day in atherothrombotic risk reduction  Academic Article
• Life-Threatening Thrombosis in Mice With Targeted Arg48-to-Cys Mutation of the Heparin-Binding Domain of Antithrombin  Academic Article
• Long-term use of left ventricular assist devices: a report on clinical outcomes  Academic Article
• Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis  Academic Article
• Low Molecular Weight Heparin  Academic Article
• Low molecular weight heparin  Academic Article
• Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer  Academic Article
• Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer  Academic Article
• Low molecular weight heparin: a critical analysis of clinical trials.  Academic Article
• Low-Intensity Warfarin Is Ineffective for the Prevention of PTFE Graft Failure in Patients on Hemodialysis  Academic Article
• Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial  Academic Article
• Low-Molecular-Weight Heparins  Academic Article
• Low-Molecular-Weight Heparins  Academic Article
• Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review  Academic Article
• Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis  Academic Article
• Lung cancer chemotherapy agents increase procoagulant activity via protein disulfide isomerase-dependent tissue factor decryption  Academic Article
• Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery.  Academic Article
• Management of Antiphospholipid Antibody Syndrome  Academic Article
• Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures  Academic Article
• Management of a Left Atrial Appendage Thrombus Due to Atrial Fibrillation Complicating Québec Platelet Disorder  Academic Article
• Management of a Thrombus in a Dolichoectatic Basilar Artery Secondary to Fabry Disease  Academic Article
• Management of bleeding in patients on antithrombotics: maintaining the balance between thrombosis and hemorrhage  Academic Article
• Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses  Academic Article
• Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy  Academic Article
• Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides  Academic Article
• Mechanism of Action and Monitoring of Anticoagulants  Academic Article
• Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo  Academic Article
• Mechanisms in thrombosis  Article
• Mechanisms of ADAMTS13 regulation  Academic Article
• Medical device‐induced thrombosis: what causes it and how can we prevent it?  Academic Article
• Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention  Academic Article
• Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Academic Article
• Microangiopathic Haemolytic Anaemia and Mucin-forming Adenocarcinoma  Academic Article
• Microangiopathic Haemolytic Anaemia: the Experimental Production of Haemolysis and Red-Cell Fragmentation by Defibrination in Vivo  Academic Article
• Microvascular Thrombosis and Ischaemic Limb Losses in Critically Ill Patients  Academic Article
• Mimicking the fibrinolytic system on material surfaces  Academic Article
• Minimizing costs for treating deep vein thrombosis: the role for fondaparinux  Academic Article
• Modes and consequences of thrombin's interaction with fibrin  Academic Article
• Modification of platelet function  Article
• Molecular Basis for the Resistance of Fibrin-Bound Thrombin to Inactivation by Heparin/Serpin Complexes  Academic Article
• Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound  Academic Article
• Neonatal Aortic Thrombosis: A Comprehensive Review  Academic Article
• Neonatal Thrombosis: Are We Doing the Right Studies?  Academic Article
• Neonatal and childhood right atrial thrombosis  Academic Article
• Neonatal and childhood right atrial thrombosis: recognition and a risk-stratified treatment approach  Academic Article
• Neonatal central venous catheter thrombosis  Academic Article
• Neutrophil and Monocyte Counts in Heparin-Induced Thrombocytopenia  Academic Article
• New Anticoagulant Drugs  Academic Article
• New Anticoagulant Therapy  Academic Article
• New Anticoagulants  Academic Article
• New Anticoagulants  Academic Article
• New Antithrombotic Drugs  Academic Article
• New Antithrombotics  Academic Article
• New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes  Academic Article
• New anticoagulant drugs.  Academic Article
• New anticoagulants: Moving beyond the direct oral anticoagulants  Academic Article
• New anticoagulants: an update.  Academic Article
• New antithrombotic agents  Academic Article
• New developments in anticoagulants: Past, present and future  Academic Article
• New oral anticoagulants: which one should my patient use?  Academic Article
• Non-Steroidal Anti-Inflammatory Agents and Coronary Heart Disease  Academic Article
• Non-Vitamin K Antagonist Oral Anticoagulants  Academic Article
• Nonbacterial Thrombotic Endocarditis Complicating Mitral Valve Prolapse Presenting as Parinaud's Syndrome — A Case Report  Academic Article
• North American and British guidelines for anti-thrombotic therapy: are we reaching consensus?  Conference Paper
• Novel anticoagulant agents: introduction  Academic Article
• Objectives and methodology: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)  Academic Article
• Occult Amebic Liver Abscess as Cause of Extensive Inferior Vena Cava and Hepatic Vein Thrombosis  Academic Article
• Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbits  Academic Article
• Optical Densities Reduce Odds of Heparin-induced Thrombocytopenia Over-diagnosis  Academic Article
• Optimal dose for starting and maintaining low-dose aspirin  Academic Article
• Optimal reversal of vitamin K antagonists  Academic Article
• Optimal timing of starting thromboprophylaxis for patients with acute spinal cord injury: A survey of Canadian spine surgeons  Academic Article
• Oral Anticoagulant Therapy  Academic Article
• Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation  Academic Article
• Oral Anticoagulation Treatment in the Elderly  Academic Article
• Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery Disease, and Peripheral Arterial Disease  Academic Article
• Oral Direct Factor Xa Inhibitors  Academic Article
• Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts  Academic Article
• Orally Active Direct Thrombin Inhibitors  Academic Article
• Organ Distribution of Fibrin in Disseminated Intravascular Coagulation  Academic Article
• Outcomes following neonatal portal vein thrombosis: A descriptive, single-center study and review of anticoagulant therapy  Academic Article
• Overview of Therapeutic Approaches for Cholesterol Lowering and Attenuation of Thrombosis for Prevention of Atherothrombosis  Academic Article
• PBMCs-Derived microRNA Signature as a Prethrombotic Status Discriminator in Stable Coronary Artery Disease  Academic Article
• PLATELET SUPPRESSIVE THERAPY  Academic Article
• PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients  Academic Article
• Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia  Academic Article
• Parenteral Anticoagulants  Academic Article
• Pathobiologic features and prevention of thrombotic complications associated with prosthetic heart valves: Fundamental principles and the contribution of platelets and thrombin  Academic Article
• Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial  Academic Article
• Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Academic Article
• Pediatric Thrombophilia  Academic Article
• Pediatric edition thrombosis research  Academic Article
• Perioperative Anticoagulation in Patients with Mechanical Heart Valves Undergoing Elective Surgery: Results of a Survey Conducted among Korean Physicians  Academic Article
• Perioperative Management of Antithrombotic Therapy  Academic Article
• Perioperative Management of the Direct Oral Anticoagulants  Academic Article
• Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians  Academic Article
• Perioperative management of antithrombotic therapy: a case-based narrative review  Academic Article
• Perioperative management of antithrombotic therapy: lifting the fog  Academic Article
• Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications  Academic Article
• Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH  Academic Article
• Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery  Academic Article
• Periprocedural risk of bleeding and thrombosis: to bridge or not to bridge. Dr. James Douketis in an interview with Dr. Roman Jaeschke: part 2  Academic Article
• Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH  Academic Article
• Pharmacological Actions of Sulodexide  Academic Article
• Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research  Academic Article
• Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis  Academic Article
• Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities  Academic Article
• Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor  Academic Article
• Plasma fibronectin supports hemostasis and regulates thrombosis  Academic Article
• Platelet Consumption in Cardiovascular Disease  Academic Article
• Platelet PECAM-1 inhibits thrombus formation in vivo  Academic Article
• Platelet activation–an overview  Article
• Platelet and fibrinogen turnover at the exposed subendothelium measured over 1 year after a balloon catheter de-endothelializing injury to the rabbit aorta:  Academic Article
• Platelet factor 4 inhibits ADAMTS13 activity and regulates the multimeric distribution of von Willebrand factor  Academic Article
• Platelet inhibitors in the treatment of thrombosis.  Academic Article
• Platelet survival and thrombosis.  Academic Article
• Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein.  Academic Article
• Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome  Academic Article
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Academic Article
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Academic Article
• Platelet-activating anti-PF4 disorders: An overview  Academic Article
• Platelet-active drugs : the relationships among dose, effectiveness, and side effects.  Academic Article
• Platelets and Thrombosis in the Development of Atherosclerosis and Its Complications  Article
• Platelets, endothelium, and vessel injury  Article
• Platelets, thrombosis and atherosclerosis  Article
• Platelets: connecting clotting and lysis  Academic Article
• Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment  Academic Article
• Polyphosphate-induced thrombosis in mice is factor XII dependent and is attenuated by histidine-rich glycoprotein  Academic Article
• Polysiloxane Nanofilaments Infused with Silicone Oil Prevent Bacterial Adhesion and Suppress Thrombosis on Intranasal Splints  Academic Article
• Postoperative Low-Molecular-Weight Heparin Bridging Is Associated with an Increase in Wound Hematoma Following Surgery for Pacemakers and Implantable Defibrillators  Academic Article
• Postpartum management of women at increased risk of thrombosis--results of a Canadian pilot survey.  Academic Article
• Potential of new anticoagulants in patients with cancer  Academic Article
• Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure  Conference Paper
• Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis  Academic Article
• Predictors of clinical outcome in patients with heparin-induced thrombocytopenia treated with direct thrombin inhibition  Academic Article
• Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001  Academic Article
• Preparation and partial characterization of human plasma depleted of antithrombin-III by heparin-sepharose affinity chromatography  Academic Article
• Prevalence and Management of Atrial Thrombi in Patients With Atrial Fibrillation Before Pulmonary Vein Isolation  Academic Article
• Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation  Academic Article
• Prevalence of factor V Leiden in a Canadian blood donor population.  Academic Article
• Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention  Academic Article
• Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment  Academic Article
• Prevention and treatment of thrombosis: novel strategies arising from our understanding the healthy endothelium.  Academic Article
• Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator  Academic Article
• Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?  Academic Article
• Prevention of Thrombogenesis from Whole Human Blood on Plastic Polymer by Ultrathin Monoethylene Glycol Silane Adlayer  Academic Article
• Prevention of Thrombotic Disorders in Cancer Patients Undergoing Chemotherapy  Academic Article
• Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone  Academic Article
• Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449]  Academic Article
• Prevention of left ventricular mural thrombus  Academic Article
• Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial  Academic Article
• Prevention of thrombosis in antiphospholipid syndrome  Academic Article
• Prevention of thrombus formation and growth by antithrombin III and heparin cofactor II-dependent thrombin inhibitors: Importance of heparin cofactor II  Academic Article
• Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care.  Academic Article
• Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Academic Article
• Probability of thrombosis of vascular access among hemodialysis patients treated with recombinant human erythropoietin.  Academic Article
• Proceedings of the 12th national conference on anticoagulant therapy  Academic Article
• Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis  Academic Article
• Progressive, Fatal Thrombosis Associated With Heparin-Induced Thrombocytopenia After Cardiac Surgery Despite “Therapeutic” Anticoagulation With Argatroban: Potential Role for PTT and ACT Confounding  Academic Article
• Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies  Academic Article
• Prostaglandin I2 (prostacyclin).  Academic Article
• Prostaglandins and Platelets  Academic Article
• Prosthetic Heart Valve Thrombosis  Academic Article
• Protein Z Gene Polymorphisms, Protein Z Concentrations, and Ischemic Stroke  Academic Article
• Protein Z Levels, Protein Z G79A Polymorphism, and Prothrombotic Conditions  Academic Article
• Prothrombin complex concentrate (PCC, Octaplex®) in patients requiring immediate reversal of vitamin K antagonist anticoagulation  Academic Article
• Prothrombotic Effects of Hyperhomocysteinemia and Hypercholesterolemia in ApoE-Deficient Mice  Academic Article
• Prothrombotic genetic risk factors and heparin-induced thrombocytopenia  Academic Article
• Pseudothrombosis in pregnancy.  Academic Article
• Pulmonary Embolism With Duplicated Inferior Vena Cava  Academic Article
• Quality Improvement Guidelines for Percutaneous Image-Guided Management of the Thrombosed or Dysfunctional Dialysis Circuit  Academic Article
• Quantitative analysis of catheter roughness induced by cutting and manipulation: a potential prothrombotic risk  Academic Article
• RED-BLOOD-CELL FRAGMENTATION IN MICROANGIOPATHIC HÆMOLYTIC ANÆMIA: IN-VITRO STUDIES  Academic Article
• Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Non–Small-Cell Lung Cancer With Disease-Related Anemia  Academic Article
• Rationale Behind the Development of Low Molecular Weight Heparin Derivatives  Academic Article
• Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702.  Academic Article
• Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.  Academic Article
• Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse  Academic Article
• Recent Advances in Thrombosis and Hemostasis – Part I  Academic Article
• Recent Advances in Thrombosis and Hemostasis—Part II  Academic Article
• Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia  Academic Article
• Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia  Academic Article
• Reconnaître, traiter et signaler les cas de thrombocytopénie immunitaire thrombotique induite par un vaccin  Academic Article
• Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta‐analysis  Academic Article
• Reducing vascular access morbidity: a comparative trial of two vascular access monitoring strategies  Academic Article
• Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins  Academic Article
• Reflecting on Eight Editions of the American College of Chest Physicians Antithrombotic Guidelines  Academic Article
• Refractory mixed autoimmune hemolysis, thrombocytopenia, and thrombosis: a diagnostic puzzle  Academic Article
• Relation of Atrial Fibrillation and Right-Sided Cardiac Thrombus to Outcomes in Patients With Acute Pulmonary Embolism  Academic Article
• Relationship Between Dose, Anticoagulant Effect and the Clinical Efficacy and Safety of Heparin  Conference Paper
• Relationship between vessel wall 13-HODE synthesis and vessel wall thrombogenecity following injury: Influence of salicylate and dipyridamole treatment  Academic Article
• Release of Neutrophil Extracellular Traps by Neutrophils Stimulated With Antiphospholipid Antibodies: A Newly Identified Mechanism of Thrombosis in the Antiphospholipid Syndrome  Academic Article
• Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia  Academic Article
• Reply  Academic Article
• Respiratory Failure Following Vinorelbine Tartrate Infusion in a Patient With Non-small Cell Lung Cancer  Academic Article
• Response by Jolly et al to Letters Regarding Article, “Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration”  Academic Article
• Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients  Academic Article
• Reversed diastolic flow in a renal transplant due to ureteric obstruction from intraluminal blood clot  Academic Article
• Review: Laboratory markers quantifying prothrombin activation and actions of thrombin in venous and arterial thrombosis do not accurately assess disease severity or the effectiveness of treatment  Academic Article
• Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis  Academic Article
• Risk factors for central venous catheter-related thrombosis in children  Academic Article
• Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit  Academic Article
• Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age  Academic Article
• Risk of Stent Thrombosis and Major Bleeding with Bivalirudin Compared with Active Control: A Systematic Review and Meta-analysis of Randomized Trials  Academic Article
• Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis  Academic Article
• Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: A systematic review and meta-analysis  Academic Article
• Risk, Clinical Features, and Outcomes of Thrombosis Associated With Pediatric Cardiac Surgery  Academic Article
• Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation  Academic Article
• Rivaroxaban and apixaban are less effective than enoxaparin for the prevention of catheter-induced clotting in vitro  Academic Article
• Rivaroxaban with or without aspirin for prevention of cardiovascular disease  Academic Article
• Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease  Academic Article
• Roles of thrombin and platelet membrane glycoprotein IIb/IIIa in platelet-subendothelial deposition after angioplasty in an ex vivo whole artery model.  Academic Article
• Safe bridging to warfarin in heparin-induced thrombocytopenia  Academic Article
• Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits  Academic Article
• Sensitivity of rabbit platelet and aortic cyclooxygenase to inhibition by aspirin  Academic Article
• Sequence of cellular responses in rabbit aortas following one and two injuries with a balloon catheter  Article
• Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia  Academic Article
• Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin  Academic Article
• Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is ‘shock liver’ the unrecognized provocateur of ischemic limb necrosis: reply  Academic Article
• Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is ‘shock liver’ the unrecognized provocateur of ischemic limb necrosis?  Academic Article
• Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial  Academic Article
• Should Warfarin Be Restarted After Warfarin-Associated Intracranial Hemorrhage?  Academic Article
• Site-directed mutagenesis of the P2 residue of human antithrombin  Academic Article
• Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis  Academic Article
• Smoking  Academic Article
• Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia  Academic Article
• Spontaneous thrombosis of the ulnar artery from midforearm to common digital arteries: A case report  Academic Article
• Stability and sterility of recombinant tissue plasminogen activator at −30°C  Academic Article
• Standard and Low Molecular Weight Heparin Have no Effect on Tissue Plasminogen Activator Induced Plasma Clot Lysis or Fibrinogenolysis  Academic Article
• State of the Art-A Journey through the World of Antithrombotic Therapy  Academic Article
• State-of-the-Art Mini Review: Dual-Pathway Inhibition to Reduce Arterial and Venous Thromboembolism  Academic Article
• Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves  Academic Article
• Stroke and Thromboprophylaxis in the Era of COVID-19  Academic Article
• Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective  Academic Article
• Successful Use of Thrombolysis in an Extremely Low Birth Weight, Premature Infant With Aortic Thrombosis  Academic Article
• Successful delayed thrombolysis with tissue plasminogen activator for recurrent arterial thrombosis secondary to protein S deficiency  Academic Article
• Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials  Academic Article
• Superior mesenteric vein thrombosis after the Whipple procedure: an aggressive, combined treatment approach.  Academic Article
• Supportive Care in Pediatric Cancer: The Road to Prevention of Thrombosis  Academic Article
• Surface modification of polydimethylsiloxane with a covalent antithrombin–heparin complex to prevent thrombosis  Academic Article
• Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin  Academic Article
• THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.  Academic Article
• THROMBOAORTITIS IN THE NEWBORN.  Academic Article
• THROMBOTIC TENDENCY IN SYSTEMIC LUPUS ERYTHEMATOSUS  Academic Article
• Tailoring warfarin induction doses to reflect individual and disease-specific factors  Academic Article
• Targeting Anemia with Erythropoietin during Critical Illness  Academic Article
• Technologic advances in magnetic resonance angiography.  Academic Article
• The 2022 ITAC evidence-based clinical practice guidelines: New update from the International Initiative on Thrombosis and Cancer to improve the care in patients with cancer-associated thrombosis  Academic Article
• The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients  Academic Article
• The Basement Membrane Underlying the Vascular Endothelium Is Not Thrombogenic: In Vivo and In Vitro Studies with Rabbit and Human Tissue  Academic Article
• The Effect of Antithrombin III-Independent Thrombin Inhibitors and Heparin on Fibrin Accretion onto Fibrin-Coated Polyethylene \textbar Request PDF  Academic Article
• The Effect of Thrombin Inhibitors on Tissue Plasminogen Activator Induced Thrombolysis in a Rat Model  Academic Article
• The Endothelium and Thrombosis  Academic Article
• The Epidemiology of Thrombosis With Thrombocytopenia Syndrome: Analogies With Heparin-Induced Thrombocytopenia  Academic Article
• The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis  Academic Article
• The Massive Online Needs Assessment (MONA) to inform the development of an emergency haematology educational blog series  Academic Article
• The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer  Academic Article
• The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model  Academic Article
• The blood compatibility challenge. Part 2: Protein adsorption phenomena governing blood reactivity  Academic Article
• The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial  Academic Article
• The direct thrombin inhibitor hirudin  Academic Article
• The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces  Academic Article
• The haemorrhagic and antithrombotic effects of dermatan sulphate.  Academic Article
• The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis  Academic Article
• The management of anticoagulated patients requiring dental extraction: a cross‐sectional survey of oral and maxillofacial surgeons and hematologists  Academic Article
• The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus  Academic Article
• The relation among vessel injury, thrombus formation, and platelet survival in rabbits  Academic Article
• The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin  Academic Article
• The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study  Academic Article
• The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits  Academic Article
• The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia  Academic Article
• The role of leukocytes in thrombosis  Academic Article
• The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis.  Academic Article
• The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians.  Academic Article
• The thrombogenicity of C1 esterase inhibitor (human): Review of the evidence  Academic Article
• The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: Influence of dosage regimens in rabrits  Academic Article
• The winding path towards rationale anti-thrombotic therapy to prevent stroke in patients with atrial fibrillation  Academic Article
• Theoretical and Practical Aspects of Thrombolytic Therapy  Academic Article
• Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19  Academic Article
• Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19  Academic Article
• Therapeutic strategies for thrombosis: new targets and approaches  Academic Article
• Thrombin Inhibition Is Impaired in Plasma of Sick Neonates  Academic Article
• Thromboaortitis  Academic Article
• Thromboembolic complications in children with cancer  Academic Article
• Thromboembolism in children with lymphoma  Academic Article
• Thrombogenic and Nonthromboge0nic Biological Surfaces  Academic Article
• Thrombolysis by chemically modified coagulation factor Xa  Academic Article
• Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review.  Academic Article
• Thromboprophylaxie hospitalière : doit-on adapter la dose d’énoxaparine au poids des patients ?  Academic Article
• Thromboprophylaxis during chemotherapy: NO  Academic Article
• Thromboprophylaxis in Medical Patients – Why Not For All?  Conference Paper
• Thromboprophylaxis in the intensive care unit: Focus on medical–surgical patients  Academic Article
• Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials  Academic Article
• Thrombosed posterior-inferior cerebellar artery aneurysm: a rare cerebellopontine angle tumour  Academic Article
• Thrombosis and Thromboembolic Complications in Fontan Patients  Academic Article
• Thrombosis and anticoagulation in the setting of renal or liver disease  Academic Article
• Thrombosis and anticoagulation.  Academic Article
• Thrombosis and atherosclerosis: The organization of pulmonary thromboemboli in the pig Macroscopic observations, protein, DNA, and major lipids  Academic Article
• Thrombosis and embolism in pediatric cardiomyopathy  Academic Article
• Thrombosis in Antithrombin-III Deficiency  Academic Article
• Thrombosis in Children  Academic Article
• Thrombosis in children with acute lymphoblastic leukemia  Academic Article
• Thrombosis in children with acute lymphoblastic leukemia  Academic Article
• Thrombosis in inherited factor VII deficiency  Academic Article
• Thrombosis in pediatric cancer: identifying the risk factors to improve care  Academic Article
• Thrombosis is associated with inferior survival in multiple myeloma  Academic Article
• Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from CYP‐C  Academic Article
• Thrombosis.  Academic Article
• Thrombosis: A major contributor to global disease burden  Academic Article
• Thrombosis: A major contributor to global disease burden  Academic Article
• Thrombosis: a major contributor to the global disease burden  Academic Article
• Thrombotic Complications after Substitution with a FVII Concentrate  Academic Article
• Thrombotic Complications and Thromboprophylaxis Across All Three Stages of Single Ventricle Heart Palliation  Academic Article
• Thrombotic Disorders: Diagnosis and Treatment  Academic Article
• Thrombotic End Point for Assessing Argatroban Therapy for Heparin-Induced Thrombocytopenia  Academic Article
• Thrombotic Risk in the Antiphospholipid Syndrome  Academic Article
• Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination  Academic Article
• Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination  Academic Article
• Thrombotic and Hemorrhagic Complications in Children With the Lupus Anticoagulant  Academic Article
• Thrombovascular Events Affect Quality of Life in Patients with Systemic Lupus Erythematosus  Academic Article
• Thrombus Aspiration in ST-Segment–Elevation Myocardial Infarction  Academic Article
• Thrombus formation: direct real-time observation and digital analysis of thrombus assembly in a living mouse by confocal and widefield intravital microscopy  Academic Article
• Tie2 protects the vasculature against thrombus formation in systemic inflammation  Academic Article
• Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin  Academic Article
• Tissue Factor and Thrombosis Models  Academic Article
• Tranexamic Acid in Patients Undergoing Noncardiac Surgery  Academic Article
• Transesophageal echocardiography in patients with cryptogenic ischemic stroke: A systematic review  Academic Article
• Translational Success Stories  Academic Article
• Transparent and Highly Flexible Hierarchically Structured Polydimethylsiloxane Surfaces Suppress Bacterial Attachment and Thrombosis Under Static and Dynamic Conditions  Academic Article
• Treatment Algorithm in Cancer-Associated Thrombosis: Canadian Expert Consensus  Academic Article
• Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus  Academic Article
• Treatment and Prevention of Heparin-Induced Thrombocytopenia  Academic Article
• Treatment of Heparin-Induced Thrombocytopenia  Academic Article
• Treatment of Proximal Deep Vein Thrombosis With a Novel Synthetic Compound (SR90107A/ORG31540) With Pure Anti–Factor Xa Activity  Academic Article
• Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management  Academic Article
• Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma  Academic Article
• Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective  Academic Article
• Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)  Academic Article
• Trimming of peripherally inserted central venous catheters may increase the risk of thrombosis  Academic Article
• Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti‐factor Xa levels  Academic Article
• Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder  Academic Article
• Update on heparin: what do we need to know?  Academic Article
• Updates in thrombosis in pediatrics: where are we after 20 years?  Academic Article
• Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis  Academic Article
• Use of the Pipeline Shield in the Posterior Circulation with Single Antiplatelet Therapy: A Case of Delayed In-stent Thrombosis  Academic Article
• Use of thrombolytic agents to treat neonatal thrombosis in clinical practice  Academic Article
• Using Tunneled Femoral Vein Catheters for “Urgent Start” Dialysis Patients: A Preliminary Report  Academic Article
• Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil  Academic Article
• Vaccine‐induced immune thrombotic thrombocytopenia (VITT) ‐ update on diagnosis and management considering different resources: Response to Comment from Yamada et al  Academic Article
• Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources  Academic Article
• Vascular access surveillance: an ongoing controversy  Academic Article
• Video laparoscopic surgery: is out‐of‐hospital thromboprophylaxis necessary?  Academic Article
• Vitamin K antagonists in heart disease: Current status and perspectives (Section III)  Academic Article
• Vitamin K in anticoagulation therapy  Academic Article
• Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks?  Academic Article
• Von Willebrand factor and thrombin activation in children with newly diagnosed acute lymphoblastic leukemia: An impact of peripheral blasts  Academic Article
• Warfarin Is the Preferred Therapy for Patients With Thrombotic APS  Academic Article
• Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial  Academic Article
• Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis  Academic Article
• What has been learnt from the thrombin-activatable fibrinolysis inhibitor-deficient mouse?  Academic Article
• What is the potential for overdiagnosis of heparin-induced thrombocytopenia?  Academic Article
• What we have learned about direct oral anticoagulant reversal  Academic Article
• Why Is Factor Xa Not a Better Target Than Factor IIa for Therapeutic Inhibition of Coagulation?  Academic Article
• Women’s values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review  Academic Article
• Zinc: An important cofactor in haemostasis and thrombosis  Academic Article
• [Anticoagulants and other drugs effective against thrombosis].  Academic Article
• [Congestive cardiomyopathy and left intraventricular thrombus as a manifestation of Churg-Strauss syndrome].  Academic Article
• [Hereditary thrombogenic defects in the national family registry].  Academic Article
• [Increased risk of thrombosis in FXII deficiency?].  Academic Article
• [Pathogenesis of thrombosis].  Academic Article
• [Pseudotumor aspect of ovarian vein thrombosis].  Academic Article
• [Vascular complications in reconstructive surgery of the foot].  Academic Article
• “Part of the Ritual”: Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome  Academic Article